medigraphic.com

2024, Number 4

<< Back Next >>

Enf Infec Microbiol 2024; 44 (4)

COVID -19 in indigenous communities of Chocó, Colombia

Correa GC, Rueda ZV, Gutiérrez LA, Castillo SD, Cortés PAS, Bedoya MI, Zapata RP, Velásquez TL, Hernández SJM

Language: Spanish
References: 30
Page: 143-149
PDF size: 241.16 Kb.


ABSTRACT

Background. The situation of COVID-19 in the indigenous population of Chocó, Colombia, was unknown. Our objective was to describe the sociodemographic characteristics and history of exposure to SARS-COV-2 in this population.
Methods. Cross-sectional study carried out in indigenous communities of Chocó. Sociodemographic data, medical history, symptoms and vital signs were obtained. From each person, a capillary blood sample was analyzed using Standard Q COVID-19 IGM/IGG Duo Test sd Biosensor. A nasopharyngeal and oropharyngeal swab sample was taken for SARS-COV-2/ RT-PCR testing in symptomatic people.
Results. 843 people were included. 55.6% were women, the median age was 32 years (P25: 22-P75: 43). Individuals reported low reporting of current smoking (2.9%). The most common comorbidities were hypertension (5.5%), diabetes (1.8%), and asthma (1.6%). 52.8% of people were overweight or obese. We found 33.6% positivity for the detection of IGM and/or IGG antibodies. Among the positive people, 12.22% were positive for both IGM/IGG, 16.1% for IGM and 23.7% for IGG. Among 41 people tested for SARS-COV-2/RT-PCR, 13 had positive results.
Conclusions. These results suggest active transmission of SARS-COV-2 in these communities. The concerted efforts of Western and traditional medicine are necessary to improve their health situation while respecting their cultural traditions.


REFERENCES

  1. “covid-19 data explorer. Our World in Data”. Consultadoel 5 de noviembre de 2022. Disponible en: https://ourworldindata.org/coronavirus-data.

  2. “covid-19 en Colombia. Noticias coronavirus-casos”.Consultado el 5 de noviembre de 2022. Disponibleen: https://www.ins.gov.co/Noticias/Paginas/coronavirus-casos.aspx.

  3. Hallal, P.C., Hartwig, F.P., Horta, B.L., Silveira, M.F.,Struchiner, C.J., Vidaletti, L.P. et al., “sars-cov-2 antibodyprevalence in Brazil: results from two successivenationwide serological household surveys”, The LancetGlobal Health, 2020, 8 (11). doi: 10.1016/S2214-109X(20)30387-9.

  4. Da Silva, H.P., Abreu, I.N., Lima, C.N., De Lima, A.C., DoNascimento Barbosa, A., De Oliveira, L.R. et al., “Migrationin times of pandemic: sars-cov-2 infection amongthe warao indigenous refugees in Belém, Pará, Amazonia,Brazil”, bmc Public Health, 2021, 21 (1). doi: 10.1186/s12889-021-11696-7.

  5. Stringhini, S., Wisniak, A., Piumatti, G., Azman, A.S.,Lauer, S.A., Baysson, H. et al., “Seroprevalence of anti-sars-cov-2 igg antibodies in Geneva, Switzerland (serocov-pop): a population-based study”, Lancet, 2020,396 (10247): 313-319. Disponible en: https: //doi.org/10.1016/S0140-6736 (20) 31304-0. pmid: 32534626.doi: 10.1016/S0140-6736(20)31304-0.

  6. Pollán, M., Pérez-Gómez, B., Pastor-Barriuso, R., Oteo,J., Hernán, M.A., Pérez-Olmeda, M., et al., “Prevalenceof sars-cov-2 in Spain (Ene-covid): a nationwide,population-based seroepidemiological study”, TheLancet, 2020, 396 (10250): 535-544. doi: 10.1016/S0140-6736(20)31483-5.

  7. Gudbjartsson, D.F., Helgason, A., Jonsson, H., Magnusson,O.T., Melsted, P., Norddahl, G.L. et al., “Spread ofsars-cov-2 in the Icelandic population”, New EnglandJournal of Medicine, 2020, 382 (24): 2302-2315. doi:10.1056/NEJMoa2006100.

  8. León, L., Leiteritz, R. y Nasi, C., “El Chocó: entre elconflicto y la madera”, Repositorio Uniandes, 2007.Consultado en noviembre de 2022. Disponible en:https://repositorio.uniandes.edu.co/bitstream/handle/1992/26019/u295678.pdf?sequence=1.

  9. Rodríguez, P., “Derechos humanos y seguridad fronteriza.La priorización institucional en la crisis humanitariade la inmigración de origen asiático y africano enAcandí, Chocó, en 2016”, Repositorio Institucional, PontificiaUniversidad Javeriana, 2018. Consultado el 5 denoviembre de 2022. Disponible en: https://repository.javeriana.edu.co/.

  10. Observatorio de Drogas de Colombia. Consultado el5 de noviembre de 2022. Disponible en: https://www.minjusticia.gov.co/programas-co/ODC/Paginas/Inicio.aspx.

  11. Kaplan, H.S., Trumble, B.C., Stieglitz, J., Mamany, R.M.,Cayuba, M.G., Moye, L.M. et al., “Voluntary collectiveisolation as a best response to covid-19 for indigenouspopulations? A case study and protocol from the Bolivianamazon”, The Lancet, 2020, 395 (10238): 1727-1734. doi: 10.1016/S0140-6736(20)31104-1.

  12. Power, T., Denise, W., Best, O., Brockie, T., Bearskin,L.B., Millendia, E. et al., “covid-19 and indigenous peoples:an imperative for action”, Journal of Clinical Nursing,2020, 29: 2737-2741. doi: 10.1111/jocn.15320.

  13. Cupertino, G.A., Cupertino, M.O., Gomes, A.P., Braga,L.M. y Siqueira-Batista, R., “covid-19 and Brazilian indigenouspopulations”, The American Journal of TropicalMedicine and Hygiene, 2020, 103 (2): 609-612. doi:10.4269/ajtmh.20-0563.

  14. Díaz de León-Martínez, L., De la Sierra-De la Vega, L.,Palacios-Ramírez, A., Rodríguez-Aguilar, M. y Flores-Ramírez,R., “Critical review of social, environmental andhealth risk factors in the Mexican indigenous populationand their capacity to respond to the covid-19”, Scienceof The Total Environment, 2020, 733: 139357. doi:10.1016/j.scitotenv.2020.139357.

  15. Júnior, J.G., Moreira, M.M., Pinheiro, W.R., De Amorim,L.M., Lima, C.K., Da Silva, C.G. et al., “The mental healthof those whose rights have been taken away: an essayon the mental health of indigenous peoples in theface of the 2019 coronavirus (2019-ncov) outbreak”,Psychiatry Research, 2020, 289: 113094. doi: 10.1016/j.psychres.2020.113094.

  16. Spanellis, A., Zapata-Ramírez, P.A., Golovátina-Mora, P.,Borzenkova, A. y Hernández-Sarmiento, J.M., “Usinggamification to develop shared understanding of thepandemic: covid-19 in indigenous communities ofChoco, Colombia”, ceur Workshop Proceedings, 2021,2883: 50-59.

  17. Stanley, F., Langton, M., Ward, J., McAullay, D. y Eades,S., “Australian first nations response to the pandemic:a dramatic reversal of the ‘Gap’”, Journal of Paediatricsand Child Health, 2021, 57 (12): 1853-1856. doi:10.1111/jpc.15701.

  18. Rodríguez-Lonebear, D., Barceló, N.E., Akee, R. y Carroll,S.R., “American indian reservations and covid-19: correlatesof early infection rates in the pandemic”, Journal ofPublic Health Management and Practice, 2020, 26 (4):371-377. doi: 10.1097/PHH.0000000000001206.

  19. Richmond, C.A. y Cook, C., “Creating conditions for Canadianaboriginal health equity: the promise of healthypublic policy”, Public Health Reviews, 2016, 37 (1). doi:10.1186/s40985-016-0016-5.

  20. Lawal, M.A., Shalaby, R., Chima, C., Vuong, W., Hrabok,M., Gusnowski, A. et al., “covid-19 pandemic: stress,anxiety, and depression levels highest amongst indigenouspeoples in Alberta”, Behavioral Sciences, 2021, 11(9): 115. doi: 10.3390/bs11090115.

  21. Usher, K., Bhullar, N., Sibbritt, D., Anubha Amarasena,S.S., Peng, W., Durkin, J. et al., “Influence of covid-19on the preventive health behaviours of indigenouspeoples of Australia residing in New South Wales: amixed-method study protocol”, bmj Open, 2021, 11 (9).doi: 10.1136/bmjopen-2020-047404.

  22. Aranda, Z., Arana-Cedeño, M., Meléndez-Navarro,D.M., Meneses-Navarro, S. y Sánchez-Pérez, H.J., “Acall for covid-19 immunization campaigns that addressthe specific circumstances of indigenous peoples ofLatin America and the Caribbean”, The Lancet RegionalHealth-Americas, 2021, 3: 100074. doi: 10.1016/j.lana.2021.100074.

  23. Pontes, G.S., De Melo Silva, J., Pinheiro-Silva, R., Barbosa,A.N., Santos, L.C., De Pádua Quirino Ramalho,A. et al., “Increased vulnerability to sars-cov-2 infectionamong indigenous people living in the urban area ofManaus”, Scientific Reports, 2021, 11 (1). Disponible en:https://doi.org/10.1038/s41598-021-96843-1.

  24. Aborode, A.T., Corriero, A.C., Oyeyemi, A.A. y Zakariyah,M.O., “The impact of covid-19 on indigenous people inAfrica”, Ethics, Medicine and Public Health, 2021, 19:100714. DOI: 10.1016/j.jemep.2021.100714.

  25. Alves, J.D., Abade, A.S., Peres, W.P., Borges, J.E., Santos,S.M. y Scholze, A.R., “Impact of covid-19 on theindigenous population of Brazil: a geo-epidemiologicalstudy”, Epidemiology and Infection, 2021, 149. doi:10.1017/S0950268821001849.

  26. La Marca, A., Capuzzo, M., Paglia, T., Roli, L., Trenti,T. y Nelson, S.M., “Testing for sars-cov-2 (covid-19):a systematic review and clinical guide to molecularand serological in-vitro diagnostic assays”, ReproductiveBioMedicine Online, 2020, 41 (3): 483-499. doi:10.1016/j.rbmo.2020.06.001.

  27. Ji, T., Liu, Z., Wang, G.Q., Guo, X., Akbar Khan, S., Lai,C. et al., “Detection of covid-19: a review of the currentliterature and future perspectives”, Biosensorsand Bioelectronics, 2020, 166: 112455. doi: 10.1016/j.bios.2020.112455.

  28. Chaimayo, C., Kaewnaphan, B., Tanlieng, N., Athipanyasilp,N., Sirijatuphat, R., Chayakulkeeree, M. et al., “Rapidsars-cov-2 antigen detection assay in comparisonwith real-time rt-pcr assay for laboratory diagnosis of covid-19 in Thailand”, Virology Journal, 2020, 17 (1). Disponibleen: https://doi.org/10.1186/s12985-020-01452-5.

  29. Paces, J., Strizova, Z., Smrz, D. y Cerny, J., “covid-19 andthe immune system”, Physiological Research, 2020,379-388. doi: 10.33549/physiolres.934492.

  30. Gudbjartsson, D.F., Norddahl, G.L., Melsted, P., Gunnarsdottir,K., Holm, H., Eythorsson, E. et al., “Humoral immuneresponse to sars-cov-2 in Iceland”, New EnglandJournal of Medicine, 2020, 383 (18): 1724-1734. doi:10.1056/NEJMoa2026116.




2020     |     www.medigraphic.com